Skip to content

Clinical trials

Completed Ovarian Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Completed Country / region: China Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20092
20102
20121
20131
20142
20152
20164
20178
20184
20195
20203
20215
20226
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.6
Chinese PLA General Hospital3
AstraZeneca2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Chipscreen Biosciences, Ltd.2
Fuda Cancer Hospital, Guangzhou2
Hoffmann-La Roche2
Impact Therapeutics, Inc.2
Sun Yat-sen University2
Tongji Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms54
Breast Neoplasms8
Fallopian Tube Neoplasms8
Uterine Cervical Neoplasms6
Colorectal Neoplasms5
Lung Neoplasms5
Recurrence4
Endometrial Neoplasms3
Pancreatic Neoplasms3
Prostatic Neoplasms3

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.